12 completed. 12 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 12 | Completed 12 |
| Phase 2 | 1 | Completed 1 |
Follow Cholera: new trials by email Literature Review of Cholera trials Research Report on Cholera
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Next Generation ORS: Comparing ORS With Calcium vs Standard ORS in Reducing Severity of Acute Watery Diarrhea Next Generation ORS (oral rehydration solution) (including placebo, Current standard control ORS (oral rehydration solution) - Diarrhea, Cholera | Phase 2 / Phase 3 | Completed | University of Florida | 396 | 2023-08-21 | 2026-04-14 |
| Immune Non-Inferiority, Safety and Lot-to-Lot Consistency of Oral Cholera Vaccine-Simplified Compared to Shanchol™ Oral Cholera Vaccine Simplified (OCV-S), Shanchol™ - Cholera | Phase 3 | Completed | International Vaccine Institute | 2530 | 2021-10-06 | 2023-06-22 |
| A Study of Two Doses of Oral Cholera Vaccine (Shanchol™) in Subjects Aged 1 Year and Older in Dominican Republic Shanchol™: Oral Cholera Vaccine Killed Bivalent (O1 and O139) Whole Cell - Cholera | Phase 3 | Completed | Sanofi Pasteur, a Sanofi Company | 336 | 2015-04-01 | 2018-03-26 |
| A Study of Live Oral Cholera Vaccine, PXVX200 in Healthy Older Adults PXVX0200, Placebo - Cholera | Phase 3 | Completed | Bavarian Nordic | 398 | 2014-05-01 | 2023-06-28 |
| A Phase 3 Lot to Lot Consistency Study of Live Oral Cholera Vaccine, PXVX0200 in Healthy Adults PXVX0200 Lot A, PXVX0200 Lot B, PXVX0200 Lot C - Cholera | Phase 3 | Completed | Bavarian Nordic | 3146 | 2014-05-01 | 2023-06-28 |
| Safety and Efficacy Challenge Study of Live Oral Cholera Vaccine Candidate,PXVX0200, to Prevent Cholera PXVX0200, placebo - Cholera | Phase 3 | Completed | Bavarian Nordic | 197 | 2013-09-01 | 2023-06-28 |
| Single Dose Oral Cholera Vaccine Study in Dhaka, Bangladesh Shanchol, Placebo - Cholera | Phase 3 | Completed | International Centre for Diarrhoeal Disease Research, Bangladesh | 204438 | 2012-12-09 | 2018-03-20 |
| Ciprofloxacin Multiple Dose for Adult Cholera Ciprofloxacin, Azithromycin - Cholera | Phase 3 | Completed | International Centre for Diarrhoeal Disease Research, Bangladesh | 218 | 2007-07-01 | 2011-07-12 |
| Randomized Controlled Trial of Killed Oral Cholera Vaccine in Kolkata bivalent killed whole cell oral cholera vaccine, Placebo - Diarrhea, Cholera | Phase 3 | Completed | International Vaccine Institute | 69329 | 2006-07-01 | 2014-07-31 |
| Single Dose Azithromycin in the Treatment of Adult Cholera Azithromycin - Cholera | Phase 3 | Completed | International Centre for Diarrhoeal Disease Research, Bangladesh | 220 | 2002-12-01 | 2006-07-21 |
| Single Dose Ciprofloxacin in the Treatment of Childhood Cholera:Randomized Controlled Clinical Trial Ciprofloxacin - Cholera | Phase 3 | Completed | International Centre for Diarrhoeal Disease Research, Bangladesh | 180 | 2001-05-01 | 2022-02-11 |
| Zinc Supplementation in Cholera Patients Zinc - Cholera | Phase 3 | Completed | International Centre for Diarrhoeal Disease Research, Bangladesh | 2000-11-01 | 2005-10-20 |
Diarrhea (2) · Vibrio Infections (1)
Bacterial Infections (12) · Bacterial Infections and Mycoses (12) · Gram-Negative Bacterial Infections (12) · Infections (12) · Vibrio Infections (11) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Signs and Symptoms, Digestive (2)
shanchol (3) · Azithromycin (2) · Ciprofloxacin (2) · Calcium (1) · World Health Organization oral rehydration solution (1) · Zinc (1)
International Centre for Diarrhoeal Disease Research, Bangladesh (5) · Bavarian Nordic (3) · International Vaccine Institute (2) · Sanofi Pasteur, a Sanofi Company (1) · University of Florida (1)
Bangladesh (6) · United States (3) · Australia (1) · Dominican Republic (1) · India (1) · Nepal (1)
James McCarty, MD (3) · Debasish Saha, MBBS,MS (2) · Dipika Sur, MD (1) · Julia Lynch, MD (1) · Sam Cheng, MD. PhD (1) · Swapan K Roy, MBBS,MSc,Phd (1) · Wasif A Khan, MBBS, MS (1)
PMID 16182896, PMID 16760445, PMID 18184631, PMID 19761838, PMID 19819004, PMID 21907255, PMID 22028938, PMID 23362293, PMID 24161413, PMID 27001804, PMID 27144848, PMID 27622507, PMID 28566334, PMID 29317118, PMID 29463233, PMID 29470934, PMID 29550406, PMID 29624592, PMID 29655627, PMID 30772070, PMID 31092224, PMID 31743334, PMID 31879124, PMID 38023545, PMID 38614631
R21AI169282 (1)